Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: Codexis, Inc.

Market Cap 234M 204M 189M 177M 331M 22.03B 333M 2.24B 866M 10.84B 877M 858M 37.7B P/E 2026 *
-6.65x
P/E 2027 * -8.92x
Enterprise Value 234M 204M 189M 177M 331M 22.03B 333M 2.24B 866M 10.84B 877M 858M 37.7B EV / Sales 2026 *
3.15x
EV / Sales 2027 * 2.63x
Free-Float
92.59%
Yield 2026 *
-
Yield 2027 * -
1 day+3.63%
1 week+7.08%
Current month-7.22%
1 month-0.39%
3 months+60.62%
6 months+54.82%
Current year+57.67%
1 week 2.42
Extreme 2.42
2.64
1 month 2.33
Extreme 2.33
2.9
Current year 0.96
Extreme 0.9583
2.98
1 year 0.96
Extreme 0.9583
3.87
3 years 0.96
Extreme 0.9583
6.08
5 years 0.96
Extreme 0.9583
42.01
10 years 0.96
Extreme 0.9583
42.01
Manager TitleAgeSince
Chief Executive Officer 60 2025-11-06
Director of Finance/CFO 59 2024-09-29
Chief Tech/Sci/R&D Officer - 2020-05-04
Director TitleAgeSince
Director/Board Member 66 2016-02-29
Director/Board Member 60 2025-11-06
Chairman 66 -
Date Insider Type Main position Quantity % Market Cap.
06-16Free

Director

66,350 0.0730%
06-16Free

Chairman

66,350 0.0730%
06-16Free

Director

66,350 0.0730%
Change 5-day change 1-year change 3-year change Capi.($)
+3.63%+7.08%+12.23%-12.59% 234M
+1.44%+1.71%-10.98%-6.19% 43.13B
+3.31%+5.93%+310.97%+534.70% 34.65B
+2.84%+2.14%+9.34%+41.02% 30.03B
-1.70%-7.54%+8.43%-21.94% 28B
-1.90%-1.56%+10.24%+21.21% 24.45B
-0.14%+5.86% - - 14.34B
+0.68%-1.53%+48.76%+104.27% 13.14B
-0.57%-2.43%+5.08%+4.79% 12.53B
-0.26%+1.15%+98.13%+80.47% 12.25B
Average +0.73%+1.33%+54.69%+82.86% 21.28B
Weighted average by Cap. +0.78%+1.28%+65.41%+109.92%

Financials

2026 *2027 *
Net sales 74.1M 64.63M 59.81M 56.09M 105M 6.99B 106M 709M 275M 3.44B 278M 272M 11.96B 88.93M 77.56M 71.79M 67.32M 126M 8.39B 127M 851M 330M 4.13B 334M 327M 14.35B
Net income -35.29M -30.78M -28.49M -26.71M -50.01M -3.33B -50.37M -338M -131M -1.64B -132M -130M -5.7B -26.56M -23.16M -21.44M -20.1M -37.63M -2.5B -37.9M -254M -98.45M -1.23B -99.68M -97.54M -4.29B
Net Debt - -
Logo Codexis, Inc.
Codexis, Inc. is a provider of enzymatic solutions. It is leveraging its CodeEvolver technology platform to discover, develop, enhance, and commercialize novel, high-performance enzymes and other classes of proteins. The Company utilizes its CodeEvolver technology platform to develop optimized enzymes that are used by some pharmaceutical companies to reduce their costs and improve the efficiency and productivity of their manufacturing processes for small molecule therapeutics. It is developing its Enzyme-Catalyzed Oligonucleotide Synthesis (ECO Synthesis) manufacturing platform to enable the scaled manufacture of RNA interference (RNAi) and other RNA-based therapeutics through an enzymatic route. The Company also uses the CodeEvolver platform technology to develop enzymes for the synthesis of RNAi therapeutics through its ECO Synthesis manufacturing platform, where its enzymes are poised to deliver many of the same benefits it offers in pharmaceutical manufacturing.
Employees
146
Date Price Change Volume
26-06-18 2.570 $ +3.63% 1,748,287
26-06-17 2.480 $ 0.00% 783,676
26-06-16 2.480 $ -0.40% 349,515
26-06-15 2.490 $ +3.75% 488,667
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
2.570USD
Average target price
6.583USD
Spread / Average Target
+156.16%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CDXS Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!